The first patient was dosed in a phase 2 trial studying the efficacy of sapanisertib in patients with NRF2-mutant relapsed/refractory lung cancer. A patient has been dosed in a phase 2 trial, kicking ...

"It encourages us that we are on the right track in our plans to grow a world-class lung cancer program right here in the Mid-South, the heart of the lung cancer battle zone." The Baptist Cancer ...

Exome analysis to reveal genomic markers associated with better efficacy of nivolumab in lung cancer patients. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I. This abstract does ...

Doctors use lung diffusion tests to measure how well a person’s lungs exchange oxygen and carbon dioxide. The test can detect lung damage and help diagnose lung conditions, including emphysema and ...